Computerized Tomography (CT)

Referrals for Lung Cancer CT Imaging Screening Remain Low Among Family Physicians

Most family physicians report discussing low-dose CT imaging with patients at high risk for lung cancer, but referrals for screening remain low, a study published in the journal Cancer has shown.

CT Colonography and FIT Yield Different Participation and Detection Rates

CT colonography with reduced preparation had increased participation compared with full cathartic preparation CT colonography, and detection rates were approximately 3 times higher for CT colonography compared with FIT.

Computed Tomography (CT) Scans and Cancer (Fact Sheet)

This fact sheet defines computed tomography (CT), explains its use in cancer detection, and answers questions regarding radiation exposure from CT use.

CT Scans for Lung Cancer Result in Low Number of False-Positives

Surgical intervention for a non-lung cancer diagnosis is rare following low-dose computed tomography screening for lung cancer, a study has found, and concerns that wider adoption of the screen might lead to unnecessary surgeries appears unfounded.

Lung cancer screening with computed tomography (CT) can be cost-effective

Benefit seen in long-term smokers when CT testing is done by skilled experts.

CT screening for lung cancer for Medicare beneficiaries discussed

The pros and cons of low-dose computed tomography (CT) screening for lung cancer are evlauated in relation to the Centers for Medicaid & Medicare Services (CMS) evaluation of screening coverage.

Congress strongly supports Medicare coverage of lung cancer screening

A large number of U.S. Senators and Representatives are taking the lead to support full Medicare coverage of low-dose computed tomography screening for seniors at high risk for lung cancer.

CT in the operating room allows more precise removal of small lung cancers

A new technique that brings CT imaging into the operating room will allow surgeons to precisely demarcate and remove small sub-centimeter lung nodules, leaving as much healthy tissue as possible.

ASCO: LDCT lung cancer screening model will up diagnoses

Implementation of the U.S. Preventive Services Task Force recommendations for low-dose computed tomography (LDCT) lung cancer screening is expected to increase lung cancer diagnoses and increase Medicare expenditure.

CT and mammogram show consistent breast density readings

Semiautomated computer-derived measurements are consistent with radiologist assessments, according to a study.

AAFP: Evidence lacking for low-dose CT lung cancer screening

Despite USPSTF recommendation for annual screening for high-risk adults, AAFP urges caution in screening for lung cancer with low-dose CT among high-risk individuals.

Overdiagnosis a concern in screening for lung cancer with low-dose CT

More than 18% of all lung cancers detected by low-dose computed tomography (CT) appeared to represent an overdiagnosis, according to a recently published study.

Reduced reimbursement for imaging may negatively impact patient outcomes

Drastic reimbursement cuts for image-guided breast biopsies, and other medical imaging techniques in the 2014 Medicare Fee Schedule Final Rule, may further reduce women's access to mammography and other breast cancer services.

Overdiagnosis of thyroid cancer linked to new imaging methods

There has been increasing incidence of small and indolent thyroid cancer but mortality rate has been stable since 1979.

Lung screening payoff low among low-risk patients

CT less effective preventing low-risk lung cancer mortality

Low-dose CT screening for lung cancer prevents very few deaths among those at lowest risk.

PET improves survival in limited-stage lung cancer

Persons with limited-stage small cell lung cancer (LS-SCLC) exhibited better disease control and survival when staged with positron emission tomography (PET) than did patients who did not undergo staging with PET.

Parental concern about CT scan cancer correlation

About half of parents were aware of malignancy risks associated with computed tomography (CT) scans before emergency department disclosures.

Digital chest tomography may be first stop in lung cancer screening

Digital chest tomosynthesis holds promise as a first-line tool for lung cancer screening, according to the baseline results of a single-arm, observational study.

Twice as many lung cancers detected by CT as by X-ray at initial screening

Centers in the United States can achieve a 20% reduction in lung cancer mortality with low-dose computed tomography (LDCT) versus chest X-ray (CXR) screening that was previously reported by the National Lung Screening Trial (NLST).

AATS: MnDCT better than chest x-ray at detecting lung cancer

MnDCT has similar radiation to X-ray but greater sensitivity for detecting new and recurrent cancer.

CT data help predict survival in metastatic melanoma

Computerized tomography adds to lactate dehydrogenase (LDH) levels in predicting survival among persons with metastatic melanoma on bevacizumab.

Screening current, former smokers with LDCT could avert thousands of deaths

Approximately 12,000 deaths from lung cancer could be prevented if all eligible current and past smokers were screened with low-dose computer tomography.

Low-dose CT screening could prevent ~12,000 lung cancer deaths annually

Adoption of National Lung Screening Trial regimens could prevent 12,250 deaths/year in U.S.

ACS introduces lung cancer screening guidelines

Clinicians should recommend annual lung cancer screening with low-dose CT for certain high-risk patients, according to new American Cancer Society screening guidelines.

PET imaging helps guide glioma treatment

Imaging with 18F-FLT positron emission tomography provides tumor-specific details accurately and noninvasively in persons with gliomas.

Breath test can indicate lung cancer

An analysis of breath samples from patients with pulmonary nodules distinguished benign from malignant growths in a recent study.

Pre-op SPECT/CT detected more lymph node metastasis in melanoma

Preoperative imaging detected more positive sentinel lymph nodes and improved disease-free survival among patients with cutaneous melanoma.